This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

X-Change Corp Appoints Drue Young As Vice President Of Product Development; First Television Campaign For Phytiva Brand Line Of Products Is Scheduled For The First Quarter Of 2013

DALLAS, Jan. 9, 2013 /PRNewswire/ -- X-Change Corp (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, announced today that Drue Young has been named Vice President of Product Development.

Mr. Young's experience as creative director and a designer for high-profile companies and clients in the entertainment and Fortune 500 companies, gives the Company the additional focused in-house expertise to move much faster in its new product launches. Mr. Young has previously worked with companies such as Wells Fargo Bank, Bank of America, Credit Suisse First Boston, H&R Block, Chevrolet, KIA Motors, Scion, Touchstone Pictures, Discovery Channel, SFGate.com, Universal Music Group, Wahlburgers, and rappers/actors Ice Cube, Snoop Dogg, and The Game. Drue's most recent work includes BET's "Second Coming: Will Black America Vote," a two-part documentary of President Barack Obama, which aired in September 2012.

Mr. Young has already hit the ground running, as he has been responsible for developing the previously announced Phytiva television commercials, which are slated to air early this year. Mr. Young will be responsible for releasing Phytiva's first product line into the multi-billion dollar over-the-counter cosmeceutical and nutraceutical markets through these television commercials.  The global over-the-counter market is estimated at well over several hundred billion dollars per year. The Phytiva Brand of products will have several economies of scale in this massive industry, which is designed to merit success and recognition for its shareholders.

The TV commercials will communicate Phytiva's products, mission, and unique brand-specific quality to viewers to actively provide Phytiva products across a broad, family-based demographic. Phytiva's main objective is to increase national recognition and to be accepted into the mainstream over-the-counter cosmeceutical and nutraceutical markets.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,680.53 +84.18 0.48%
S&P 500 2,057.64 -43.85 -2.09%
NASDAQ 4,958.4680 -122.0370 -2.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs